The Korea Disease Control and Prevention Agency selected Pacific Biosciences' HiFi long‑read sequencing to build a telomere‑to‑telomere Korean pangenome reference, planning more than 1,000 whole genomes and integration with the Human Pangenome Reference Consortium. PacBio will provide WGS, full‑length RNA analysis and chromosome‑scale structural variant characterization. Separately, Bio‑Techne and Oxford Nanopore extended and broadened their partnership through 2032 to develop nanopore‑based assays for heritable genetic disorders, building on joint products such as the AmplideX Nanopore Carrier Plus Kit. Both moves underscore continued momentum for long‑read sequencing in national reference projects and clinical assay development.